Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Bisquaternary ammonium compounds Bisquaternary ammonium compounds
Bisquaternary ammonium compounds and its peer markets - Chromatography Instruments,
Upcoming
Alpha-adrenoreceptor antagonists Alpha-adrenoreceptor antagonists
Alpha-adrenoreceptor antagonists and its peer markets - Proteomics,
Upcoming
Guanidine derivatives Guanidine derivatives
Guanidine derivatives and its peer markets - Immunoassay,
Upcoming
Thiazide derivatives Thiazide derivatives
Thiazide derivatives and its peer markets - Chromatography,
Upcoming
Hydrazinophthalazine derivatives Hydrazinophthalazine derivatives
Hydrazinophthalazine derivatives and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Pyrimidine derivatives Pyrimidine derivatives
Pyrimidine derivatives and its peer markets - Wireless Health,
Upcoming
Nitroferricyanide derivatives Nitroferricyanide derivatives
Nitroferricyanide derivatives and its peer markets - Immunoassay,
Upcoming
Pinacidil Pinacidil
Pinacidil and its peer markets - Digital Pathology,
Upcoming
Alkaloids, excl. rauwolfia Alkaloids, excl. rauwolfia
Alkaloids, excl. rauwolfia and its peer markets - Digital Pathology,
Upcoming
Tyrosine hydroxylase inhibitors Tyrosine hydroxylase inhibitors
Tyrosine hydroxylase inhibitors and its peer markets - Wireless Health,
Upcoming
MAO inhibitors MAO inhibitors
MAO inhibitors and its peer markets - Serotonin antagonists,
Upcoming
Serotonin antagonists Serotonin antagonists
Serotonin antagonists and its peer markets - Proteomics,
Upcoming
Rauwolfia alkaloids and diuretics in combination Rauwolfia alkaloids and diuretics in combination
Rauwolfia alkaloids and diuretics in combination and its peer markets - Proteomics,
Upcoming
Methyldopa and diuretics in combination Methyldopa and diuretics in combination
Methyldopa and diuretics in combination and its peer markets - Hydrazinophthalazine derivatives and diuretics,
Upcoming
Imidazoline receptor agonists in combination with diuretics Imidazoline receptor agonists in combination with diuretics
Imidazoline receptor agonists in combination with diuretics and its peer markets - Chromatography,
Upcoming
Alpha-adrenoreceptor antagonists and diuretics Alpha-adrenoreceptor antagonists and diuretics
Alpha-adrenoreceptor antagonists and diuretics and its peer markets - Imidazoline receptor agonists in combination with...
Upcoming
Guanidine derivatives and diuretics Guanidine derivatives and diuretics
Guanidine derivatives and diuretics and its peer markets - Chromatography Instruments,
Upcoming
Hydrazinophthalazine derivatives and diuretics Hydrazinophthalazine derivatives and diuretics
Hydrazinophthalazine derivatives and diuretics and its peer markets - E-Clinical Trial Solutions,
Upcoming
Alkaloids, excl. rauwolfia, in combination with diuretics Alkaloids, excl. rauwolfia, in combination with diuretics
Alkaloids, excl. rauwolfia, in combination with diuretics and its peer markets - Methyldopa and diuretics in combination,
Upcoming
MAO inhibitors and diuretics MAO inhibitors and diuretics
MAO inhibitors and diuretics and its peer markets - Chromatography,
Upcoming
2986 reports | Show
Connect With Us
US/CAN : +1-888-502-0539